Everest Organics [EVERESTO] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Everest Organics

BSE

Sun Pharmaceutical

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Everest Organics wins in 4 metrics, Sun Pharmaceutical wins in 15 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Everest Organics	Sun Pharmaceutical	Better
P/E Ratio (TTM)	67.51	38.00	Sun Pharmaceutical
Price-to-Book Ratio	12.73	5.47	Sun Pharmaceutical
Debt-to-Equity Ratio	68.44	3.26	Sun Pharmaceutical
PEG Ratio	-0.57	-1.95	Sun Pharmaceutical
EV/EBITDA	27.01	24.13	Sun Pharmaceutical
Profit Margin (TTM)	3.41%	19.29%	Sun Pharmaceutical
Operating Margin (TTM)	6.39%	24.34%	Sun Pharmaceutical
EBITDA Margin (TTM)	6.39%	24.34%	Sun Pharmaceutical
Return on Equity	-1.84%	15.08%	Sun Pharmaceutical
Return on Assets (TTM)	-0.57%	11.87%	Sun Pharmaceutical
Free Cash Flow (TTM)	$-108.03M	$119.44B	Sun Pharmaceutical
Dividend Yield	N/A	1.26%	N/A
1-Year Return	200.88%	-7.54%	Everest Organics
Price-to-Sales Ratio (TTM)	2.20	7.34	Everest Organics
Enterprise Value	$4.41B	$3,700.46B	Sun Pharmaceutical
EV/Revenue Ratio	2.43	6.88	Everest Organics
Gross Profit Margin (TTM)	31.15%	79.58%	Sun Pharmaceutical
Revenue per Share (TTM)	$188	$224	Sun Pharmaceutical
Earnings per Share (Diluted)	$6.11	$43.30	Sun Pharmaceutical
Beta (Stock Volatility)	0.14	0.31	Everest Organics

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Everest Organics vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Everest Organics	0.48%	12.60%	20.97%	-5.37%	66.13%	37.04%
Sun Pharmaceutical	0.91%	0.56%	-2.16%	-4.47%	0.14%	-13.13%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Everest Organics	200.88%	219.64%	46.82%	10,614.29%	10,614.29%	10,614.29%
Sun Pharmaceutical	-7.54%	86.54%	195.42%	85.21%	825.90%	2,692.65%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Everest Organics (EVERESTO): View Full Stock Overview

Sun Pharmaceutical (SUNPHARMA): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Everest Organics vs Sun Pharmaceutical

Metric	EVERESTO	SUNPHARMA
Market Information
Market Cap i	₹4.01B	₹3.95T
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	6,139	1,796,937
90 Day Avg. Volume i	2,819	2,103,189
Last Close	₹414.50	₹1,656.70
52 Week Range	₹112.50 - ₹477.00	₹1,553.05 - ₹1,960.35
% from 52W High	-13.10%	-15.49%
All-Time High	₹477.00 (May 05, 2025)	₹1,960.35 (Sep 30, 2024)
% from All-Time High	-13.10%	-15.49%
Growth Metrics
Quarterly Revenue Growth	0.66%	0.10%
Quarterly Earnings Growth	0.66%	-0.20%
Financial Health
Profit Margin (TTM) i	0.03%	0.19%
Operating Margin (TTM) i	0.06%	0.24%
Return on Equity (TTM) i	-0.02%	0.15%
Debt to Equity (MRQ) i	68.44	3.26
Cash & Liquidity
Book Value per Share (MRQ)	₹32.42	₹300.99
Cash per Share (MRQ)	₹6.85	₹108.88
Operating Cash Flow (TTM) i	₹38.10M	₹110.84B
Levered Free Cash Flow (TTM) i	₹-12,903,000	₹109.29B
Dividends
Last 12-Month Dividend Yield i	N/A	1.26%
Last 12-Month Dividend i	₹0.00	₹21.00

Valuation & Enterprise Metrics Analysis: Everest Organics vs Sun Pharmaceutical

Metric	EVERESTO	SUNPHARMA
Price Ratios
P/E Ratio (TTM) i	67.51	38.00
Forward P/E i	N/A	50.35
PEG Ratio i	-0.57	-1.95
Price to Sales (TTM) i	2.20	7.34
Price to Book (MRQ) i	12.73	5.47
Market Capitalization
Market Capitalization i	₹4.01B	₹3.95T
Enterprise Value i	₹4.41B	₹3.70T
Enterprise Value Metrics
Enterprise to Revenue i	2.43	6.88
Enterprise to EBITDA i	27.01	24.13
Risk & Other Metrics
Beta i	0.14	0.31
Book Value per Share (MRQ) i	₹32.42	₹300.99

Financial Statements Comparison: Everest Organics vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	EVERESTO	SUNPHARMA
Revenue/Sales i	₹538.13M	₹137.86B
Cost of Goods Sold i	₹370.51M	₹28.15B
Gross Profit i	₹167.63M	₹109.71B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹29.21M	₹33.72B
EBITDA i	₹49.86M	₹47.66B
Pre-Tax Income i	₹21.64M	₹31.73B
Income Tax i	₹7.59M	₹8.70B
Net Income (Profit) i	₹14.05M	₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	EVERESTO	SUNPHARMA
Cash & Equivalents i	₹60.92M	₹102.69B
Total Current Assets i	₹1.48B	₹526.24B
Total Current Liabilities i	₹1.40B	₹181.94B
Long-Term Debt i	₹91.98M	₹3.58B
Total Shareholders Equity i	₹699.47M	₹724.86B
Retained Earnings i	N/A	₹578.62B
Property, Plant & Equipment i	₹483.39M	₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	EVERESTO	SUNPHARMA
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	EVERESTO	SUNPHARMA
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	6,139	1,796,937
Average Daily Volume (90 Day) i	2,819	2,103,189
Shares Outstanding i	9.71M	2.40B
Float Shares i	1.93M	1.04B
% Held by Insiders i	0.78%	0.56%
% Held by Institutions i	0.00%	0.25%

Dividend Analysis & Yield Comparison: Everest Organics vs Sun Pharmaceutical

Metric	EVERESTO	SUNPHARMA
Last 12-Month Dividend i	₹0.00	₹21.00
Last 12-Month Dividend Yield i	N/A	1.26%
3-Year Avg Annual Dividend i	₹0.17	₹14.67
3-Year Avg Dividend Yield i	0.35%	0.46%
3-Year Total Dividends i	₹0.50	₹44.00
Ex-Dividend Date	Sep 15, 2022	Jul 07, 2025

Everest Organics [EVERESTO] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison